BMF and cancer: Taken together, we demonstrate that TEAD inhibition could be an exploitable vulnerability across multiple malignant tumor models besides mesothelioma and that upregulation of BMF gene is a common phenomenon in those cancer cells with sensitive antiproliferative response to TEAD inhibitor.